Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy — Amir Ajoolabady (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Shared by
Guido Guido Kroemer
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Article
2022
en
Authors
+1 more
AA
Amir Ajoolabady
DT
Daolin Tang
Guido Guido Kroemer
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2023
Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang
,
Guido Guido Kroemer
,
Rui Kang
Article
2008
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet
,
Jordi Bruix
Hepatology
Article
2011
Targeted Therapies for Hepatocellular Carcinoma
Augusto Villanueva
,
Josep M. Llovet
Gastroenterology
Article
2025
Development and regulatory approval of a new systemic targeted therapy for advanced hepatocellular carcinoma.
Boris Pasche
,
Al B. Benson
,
Masatoshi Kudo
,
Anthony F. Shields
,
Hugo Jimenez
,
Alexandre Barbault
Article
2021
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Jian Jian Kang
,
Natalie Brajanovski
,
Keefe T. Chan
,
Jiachen Xuan
,
Richard B. Pearson
,
Elaine Sanij
Discussion(0)
No comments yet. Be the first to comment.